Global Autologous Platelet Rich Plasma (PRP) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Autologous Platelet Rich Plasma (PRP) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Platelet-rich plasma (PRP) therapy speeds healing of injured tendons, ligaments, muscles and joints by injecting a concentration of the patient's own platelets.
Global Autologous Platelet Rich Plasma (PRP) market is projected to reach US$ 13280 million in 2033, increasing from US$ 5482 million in 2022, with the CAGR of 14.0% during the period of 2023 to 2033. Demand from Orthopedic Surgery and Plastic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Autologous Platelet Rich Plasma (PRP) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Autologous Platelet Rich Plasma (PRP) key manufacturers include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex, Regen Lab, Exactech, Weigao and Emcyte Corporation, etc. Harvest Technologies, DePuy Synthes, Stryker are top 3 players and held % sales share in total in 2022.
Autologous Platelet Rich Plasma (PRP) can be divided into P-PRP, L-PRP and PRF,, etc. P-PRP is the mainstream product in the market, accounting for % sales share globally in 2022.
Autologous Platelet Rich Plasma (PRP) is widely used in various fields, such as Orthopedic Surgery, Plastic Surgery, General Surgery and Others, etc. Orthopedic Surgery provides greatest supports to the Autologous Platelet Rich Plasma (PRP) industry development. In 2022, global % sales of Autologous Platelet Rich Plasma (PRP) went into Orthopedic Surgery filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Autologous Platelet Rich Plasma (PRP) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Regen Lab
Exactech
Weigao
Emcyte Corporation
REV-MED
Segment by Type
P-PRP
L-PRP
PRF
Orthopedic Surgery
Plastic Surgery
General Surgery
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Autologous Platelet Rich Plasma (PRP) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Autologous Platelet Rich Plasma (PRP), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Autologous Platelet Rich Plasma (PRP) industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Autologous Platelet Rich Plasma (PRP) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Autologous Platelet Rich Plasma (PRP) introduction, etc. Autologous Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Autologous Platelet Rich Plasma (PRP) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Global Autologous Platelet Rich Plasma (PRP) market is projected to reach US$ 13280 million in 2033, increasing from US$ 5482 million in 2022, with the CAGR of 14.0% during the period of 2023 to 2033. Demand from Orthopedic Surgery and Plastic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Autologous Platelet Rich Plasma (PRP) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Autologous Platelet Rich Plasma (PRP) key manufacturers include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex, Regen Lab, Exactech, Weigao and Emcyte Corporation, etc. Harvest Technologies, DePuy Synthes, Stryker are top 3 players and held % sales share in total in 2022.
Autologous Platelet Rich Plasma (PRP) can be divided into P-PRP, L-PRP and PRF,, etc. P-PRP is the mainstream product in the market, accounting for % sales share globally in 2022.
Autologous Platelet Rich Plasma (PRP) is widely used in various fields, such as Orthopedic Surgery, Plastic Surgery, General Surgery and Others, etc. Orthopedic Surgery provides greatest supports to the Autologous Platelet Rich Plasma (PRP) industry development. In 2022, global % sales of Autologous Platelet Rich Plasma (PRP) went into Orthopedic Surgery filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Autologous Platelet Rich Plasma (PRP) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Regen Lab
Exactech
Weigao
Emcyte Corporation
REV-MED
Segment by Type
P-PRP
L-PRP
PRF
Segment by Application
Orthopedic Surgery
Plastic Surgery
General Surgery
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Autologous Platelet Rich Plasma (PRP) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Autologous Platelet Rich Plasma (PRP), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Autologous Platelet Rich Plasma (PRP) industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Autologous Platelet Rich Plasma (PRP) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Autologous Platelet Rich Plasma (PRP) introduction, etc. Autologous Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Autologous Platelet Rich Plasma (PRP) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.